In all cases, dont hesitate to reach out to your healthcare provider if GLP-1 side effects are impeding your life, including staying hydrated
Novo Nordisk price cuts create competitive headwinds The primary factor driving recent weakness stems from escalating price competition in GLP-1 obesity treatments, where Hims & Hers is attempting to establish a foothold
Risks of gallbladder issues, particularly gallstones, appear to be relatively high, with one study suggesting a chance of up to 28%.18 Another danger involves the increased risk of thyroid cancer, which requires more study but is undeniably present
Nauck MA, Holst JJ, Willms B.: Glucagon-like peptide 1 and its potential in the treatment of non-insulin dependent diabetes mellitus
Some may lose more, especially with higher starting BMI and strict diet/exercise
In very rare situations, systemic allergic reactions need emergency treatment